Zcube
VC Fund
Bresso, Italy
Zcube is a VC fund in Bresso focused on Health Care and Medical Device. Zcube is the Research Venture of the Zambon Group. It was established in 2003 to explore innovation and research in the Life Science field on a global level. Zcube has three work streams: Zcare, Open Accelerator, investments in national and international funds. It supports the development and acceleration of innovative startups
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Zcube invests in
Stages Zcube invests in
Countries Zcube invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $56k–$1.5M
Investment Focus
Industry
- Health Care 2 (40%)
- Medical Device 2 (40%)
- Medical 1 (20%)
- mHealth 1 (20%)
- Biopharma 1 (20%)
Stage
- Seed 2 (40%)
- Pre-Seed 1 (20%)
- Series B 1 (20%)
Country
- Italy 1 (20%)
- Canada 1 (20%)
- Lithuania 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Elena Zambon
President
|
President | Total investments: 2 | Find email | |
Orientina Di Giovanni
Chief of Zcare Division
|
Chief of Zcare Division | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Hyivy Health creates an intelligent and holistic pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Our device provides the first quantifiable data set on the pelvic floor and 3 different therapies from multiple sensors and mechanical functions to help keep track ofprogress, adapt treatment plans and provide more effective, comfortable rehab experiences. | $1.5M / Seed / Sep 24, 2024 | ||
| Vilimed specialises in the development of medical devices like Vilim ball which is a therapeutic device developed for hand tremor reduction. | $55.6K / Seed / Mar 02, 2022 | ||
| Hyivy Health creates an intelligent and holistic pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Our device provides the first quantifiable data set on the pelvic floor and 3 different therapies from multiple sensors and mechanical functions to help keep track ofprogress, adapt treatment plans and provide more effective, comfortable rehab experiences. | $1M / Pre-Seed / Jan 18, 2022 | ||
PharmEste
|
PharmEste s.r.l., a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain. | $5.3M / Series B / Jun 01, 2011 | |
| See all 5 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Zcube invest in?
Zcube invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Zcube invest in?
Zcube typically joins rounds of $56k–$1.5M at Seed. These are whole funding-round sizes, not Zcube's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Zcube took part in.
How do I contact Zcube?
Public channels for Zcube include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Zcube?
The team at Zcube includes Elena Zambon (President) and Orientina Di Giovanni (Chief of Zcare Division). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
